Intrinsic value of LHC Group - LHCG

Previous Close

$93.84

  Intrinsic Value

$69.30

stock screener

  Rating & Target

sell

-26%

Previous close

$93.84

 
Intrinsic value

$69.30

 
Up/down potential

-26%

 
Rating

sell

We calculate the intrinsic value of LHCG stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.7

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  17.20
  15.98
  14.88
  13.89
  13.00
  12.20
  11.48
  10.84
  10.25
  9.73
  9.25
  8.83
  8.45
  8.10
  7.79
  7.51
  7.26
  7.03
  6.83
  6.65
  6.48
  6.33
  6.20
  6.08
  5.97
  5.88
  5.79
  5.71
  5.64
  5.57
Revenue, $m
  1,256
  1,457
  1,674
  1,907
  2,155
  2,417
  2,695
  2,987
  3,293
  3,614
  3,948
  4,297
  4,659
  5,037
  5,429
  5,837
  6,261
  6,702
  7,159
  7,635
  8,130
  8,645
  9,181
  9,740
  10,322
  10,928
  11,561
  12,221
  12,910
  13,629
Variable operating expenses, $m
  1,151
  1,326
  1,516
  1,719
  1,935
  2,165
  2,408
  2,663
  2,931
  3,210
  3,450
  3,755
  4,072
  4,401
  4,744
  5,101
  5,471
  5,856
  6,256
  6,672
  7,105
  7,555
  8,023
  8,511
  9,019
  9,549
  10,102
  10,679
  11,281
  11,910
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  1,151
  1,326
  1,516
  1,719
  1,935
  2,165
  2,408
  2,663
  2,931
  3,210
  3,450
  3,755
  4,072
  4,401
  4,744
  5,101
  5,471
  5,856
  6,256
  6,672
  7,105
  7,555
  8,023
  8,511
  9,019
  9,549
  10,102
  10,679
  11,281
  11,910
Operating income, $m
  106
  131
  158
  188
  219
  252
  287
  324
  363
  403
  498
  542
  588
  635
  685
  736
  790
  845
  903
  963
  1,026
  1,091
  1,158
  1,229
  1,302
  1,379
  1,458
  1,542
  1,629
  1,719
EBITDA, $m
  219
  254
  291
  332
  375
  421
  469
  520
  573
  629
  687
  748
  811
  877
  945
  1,016
  1,090
  1,166
  1,246
  1,329
  1,415
  1,505
  1,598
  1,695
  1,797
  1,902
  2,012
  2,127
  2,247
  2,372
Interest expense (income), $m
  3
  8
  11
  14
  18
  22
  27
  31
  36
  41
  46
  52
  58
  64
  70
  77
  83
  90
  98
  105
  113
  122
  130
  139
  148
  158
  168
  179
  190
  201
  213
Earnings before tax, $m
  98
  120
  144
  170
  197
  226
  256
  288
  322
  357
  446
  484
  524
  565
  608
  653
  699
  748
  798
  850
  904
  960
  1,019
  1,080
  1,144
  1,210
  1,280
  1,352
  1,428
  1,506
Tax expense, $m
  26
  32
  39
  46
  53
  61
  69
  78
  87
  96
  120
  131
  142
  153
  164
  176
  189
  202
  215
  229
  244
  259
  275
  292
  309
  327
  346
  365
  385
  407
Net income, $m
  72
  88
  105
  124
  144
  165
  187
  210
  235
  261
  326
  354
  383
  413
  444
  477
  511
  546
  582
  620
  660
  701
  744
  789
  835
  884
  934
  987
  1,042
  1,100

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  930
  1,079
  1,239
  1,411
  1,595
  1,789
  1,995
  2,211
  2,438
  2,675
  2,922
  3,180
  3,449
  3,728
  4,019
  4,321
  4,634
  4,960
  5,299
  5,652
  6,018
  6,399
  6,796
  7,209
  7,640
  8,089
  8,557
  9,046
  9,556
  10,088
Adjusted assets (=assets-cash), $m
  930
  1,079
  1,239
  1,411
  1,595
  1,789
  1,995
  2,211
  2,438
  2,675
  2,922
  3,180
  3,449
  3,728
  4,019
  4,321
  4,634
  4,960
  5,299
  5,652
  6,018
  6,399
  6,796
  7,209
  7,640
  8,089
  8,557
  9,046
  9,556
  10,088
Revenue / Adjusted assets
  1.351
  1.350
  1.351
  1.352
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
  1.351
Average production assets, $m
  602
  698
  802
  913
  1,032
  1,158
  1,291
  1,431
  1,578
  1,731
  1,891
  2,058
  2,232
  2,413
  2,601
  2,796
  2,999
  3,210
  3,429
  3,657
  3,894
  4,141
  4,398
  4,665
  4,944
  5,235
  5,538
  5,854
  6,184
  6,528
Working capital, $m
  -53
  -61
  -70
  -80
  -90
  -102
  -113
  -125
  -138
  -152
  -166
  -180
  -196
  -212
  -228
  -245
  -263
  -281
  -301
  -321
  -341
  -363
  -386
  -409
  -434
  -459
  -486
  -513
  -542
  -572
Total debt, $m
  203
  268
  337
  412
  492
  576
  665
  759
  858
  960
  1,068
  1,180
  1,296
  1,418
  1,544
  1,675
  1,811
  1,952
  2,099
  2,252
  2,411
  2,577
  2,749
  2,928
  3,115
  3,310
  3,513
  3,725
  3,947
  4,178
Total liabilities, $m
  404
  468
  538
  612
  692
  777
  866
  960
  1,058
  1,161
  1,268
  1,380
  1,497
  1,618
  1,744
  1,875
  2,011
  2,153
  2,300
  2,453
  2,612
  2,777
  2,949
  3,129
  3,316
  3,511
  3,714
  3,926
  4,147
  4,378
Total equity, $m
  526
  610
  701
  799
  903
  1,013
  1,129
  1,251
  1,380
  1,514
  1,654
  1,800
  1,952
  2,110
  2,275
  2,446
  2,623
  2,808
  2,999
  3,199
  3,406
  3,622
  3,847
  4,080
  4,324
  4,578
  4,843
  5,120
  5,408
  5,710
Total liabilities and equity, $m
  930
  1,078
  1,239
  1,411
  1,595
  1,790
  1,995
  2,211
  2,438
  2,675
  2,922
  3,180
  3,449
  3,728
  4,019
  4,321
  4,634
  4,961
  5,299
  5,652
  6,018
  6,399
  6,796
  7,209
  7,640
  8,089
  8,557
  9,046
  9,555
  10,088
Debt-to-equity ratio
  0.390
  0.440
  0.480
  0.520
  0.540
  0.570
  0.590
  0.610
  0.620
  0.630
  0.650
  0.660
  0.660
  0.670
  0.680
  0.680
  0.690
  0.700
  0.700
  0.700
  0.710
  0.710
  0.710
  0.720
  0.720
  0.720
  0.730
  0.730
  0.730
  0.730
Adjusted equity ratio
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566
  0.566

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  72
  88
  105
  124
  144
  165
  187
  210
  235
  261
  326
  354
  383
  413
  444
  477
  511
  546
  582
  620
  660
  701
  744
  789
  835
  884
  934
  987
  1,042
  1,100
Depreciation, amort., depletion, $m
  113
  122
  133
  144
  156
  168
  182
  196
  210
  226
  189
  206
  223
  241
  260
  280
  300
  321
  343
  366
  389
  414
  440
  467
  494
  523
  554
  585
  618
  653
Funds from operations, $m
  184
  210
  238
  268
  300
  333
  369
  406
  445
  486
  515
  559
  606
  654
  704
  756
  811
  867
  925
  986
  1,049
  1,115
  1,184
  1,255
  1,330
  1,407
  1,488
  1,572
  1,660
  1,752
Change in working capital, $m
  -8
  -8
  -9
  -10
  -10
  -11
  -12
  -12
  -13
  -13
  -14
  -15
  -15
  -16
  -16
  -17
  -18
  -18
  -19
  -20
  -21
  -22
  -23
  -23
  -24
  -25
  -27
  -28
  -29
  -30
Cash from operations, $m
  192
  219
  247
  278
  310
  344
  380
  418
  458
  500
  529
  574
  621
  670
  721
  773
  828
  885
  945
  1,006
  1,070
  1,137
  1,206
  1,279
  1,354
  1,433
  1,515
  1,600
  1,689
  1,783
Maintenance CAPEX, $m
  -51
  -60
  -70
  -80
  -91
  -103
  -116
  -129
  -143
  -158
  -173
  -189
  -206
  -223
  -241
  -260
  -280
  -300
  -321
  -343
  -366
  -389
  -414
  -440
  -467
  -494
  -523
  -554
  -585
  -618
New CAPEX, $m
  -89
  -96
  -104
  -111
  -119
  -126
  -133
  -140
  -147
  -153
  -160
  -167
  -174
  -181
  -188
  -195
  -203
  -211
  -219
  -228
  -237
  -247
  -257
  -267
  -279
  -291
  -303
  -316
  -330
  -345
Cash from investing activities, $m
  -140
  -156
  -174
  -191
  -210
  -229
  -249
  -269
  -290
  -311
  -333
  -356
  -380
  -404
  -429
  -455
  -483
  -511
  -540
  -571
  -603
  -636
  -671
  -707
  -746
  -785
  -826
  -870
  -915
  -963
Free cash flow, $m
  52
  62
  73
  86
  100
  115
  132
  149
  168
  189
  196
  218
  241
  266
  291
  318
  346
  374
  404
  435
  467
  501
  535
  571
  609
  648
  688
  730
  774
  820
Issuance/(repayment) of debt, $m
  59
  64
  70
  75
  80
  84
  89
  94
  98
  103
  107
  112
  117
  121
  126
  131
  136
  141
  147
  153
  159
  165
  172
  179
  187
  195
  203
  212
  221
  231
Issuance/(repurchase) of shares, $m
  6
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  65
  64
  70
  75
  80
  84
  89
  94
  98
  103
  107
  112
  117
  121
  126
  131
  136
  141
  147
  153
  159
  165
  172
  179
  187
  195
  203
  212
  221
  231
Total cash flow (excl. dividends), $m
  117
  127
  143
  161
  180
  200
  221
  243
  267
  291
  303
  330
  358
  387
  418
  449
  482
  516
  551
  588
  626
  666
  708
  751
  796
  842
  891
  942
  995
  1,051
Retained Cash Flow (-), $m
  -77
  -84
  -91
  -97
  -104
  -110
  -116
  -122
  -128
  -134
  -140
  -146
  -152
  -158
  -164
  -171
  -178
  -185
  -192
  -199
  -207
  -216
  -225
  -234
  -244
  -254
  -265
  -277
  -289
  -302
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  6
  8
  9
  10
  11
  13
  15
  16
  18
  20
  22
  24
  26
  28
  30
  33
  35
  38
  40
  43
  46
  49
  52
  55
  58
  62
  66
  69
  73
  77
Cash available for distribution, $m
  40
  43
  52
  63
  76
  89
  105
  121
  139
  157
  163
  184
  206
  229
  253
  278
  304
  331
  360
  389
  419
  450
  483
  517
  552
  588
  626
  666
  707
  749
Discount rate, %
  5.10
  5.36
  5.62
  5.90
  6.20
  6.51
  6.83
  7.18
  7.54
  7.91
  8.31
  8.72
  9.16
  9.62
  10.10
  10.60
  11.13
  11.69
  12.27
  12.89
  13.53
  14.21
  14.92
  15.66
  16.45
  17.27
  18.13
  19.04
  19.99
  20.99
PV of cash for distribution, $m
  38
  38
  44
  50
  56
  61
  66
  69
  72
  73
  68
  67
  66
  63
  60
  55
  51
  45
  40
  34
  29
  24
  20
  16
  12
  9
  7
  5
  4
  2
Current shareholders' claim on cash, %
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7
  99.7

LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, and emotional and spiritual support. Its community-based service operations offer a range of services to patients in their home or in a medical facility. The services range from assistance with grooming, medication reminders and meal preparation. It provides facility-based services principally through its LTACHs.

FINANCIAL RATIOS  of  LHC Group (LHCG)

Valuation Ratios
P/E Ratio 44.6
Price to Sales 1.8
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow 24.7
Price to Free Cash Flow 32.4
Growth Rates
Sales Growth Rate 12.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -81%
Cap. Spend. - 3 Yr. Gr. Rate -14.5%
Financial Strength
Quick Ratio NaN
Current Ratio 0.1
LT Debt to Equity 22.3%
Total Debt to Equity 22.3%
Interest Coverage 24
Management Effectiveness
Return On Assets 6.6%
Ret/ On Assets - 3 Yr. Avg. 6%
Return On Total Capital 7.9%
Ret/ On T. Cap. - 3 Yr. Avg. 7.3%
Return On Equity 9.9%
Return On Equity - 3 Yr. Avg. 8.9%
Asset Turnover 1.6
Profitability Ratios
Gross Margin 39%
Gross Margin - 3 Yr. Avg. 40.3%
EBITDA Margin 9.1%
EBITDA Margin - 3 Yr. Avg. 8.7%
Operating Margin 7.8%
Oper. Margin - 3 Yr. Avg. 7.4%
Pre-Tax Margin 7.4%
Pre-Tax Margin - 3 Yr. Avg. 7.1%
Net Profit Margin 4%
Net Profit Margin - 3 Yr. Avg. 3.7%
Effective Tax Rate 32.4%
Eff/ Tax Rate - 3 Yr. Avg. 33.4%
Payout Ratio 0%

LHCG stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the LHCG stock intrinsic value calculation we used $1072 million for the last fiscal year's total revenue generated by LHC Group. The default revenue input number comes from 2017 income statement of LHC Group. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our LHCG stock valuation model: a) initial revenue growth rate of 17.2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 5.1%, whose default value for LHCG is calculated based on our internal credit rating of LHC Group, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of LHC Group.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of LHCG stock the variable cost ratio is equal to 92.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for LHCG stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for LHC Group.

Corporate tax rate of 27% is the nominal tax rate for LHC Group. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the LHCG stock is equal to 0.6%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for LHCG are equal to 47.9%.

Life of production assets of 10 years is the average useful life of capital assets used in LHC Group operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for LHCG is equal to -4.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $449 million for LHC Group - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 18 million for LHC Group is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of LHC Group at the current share price and the inputted number of shares is $1.7 billion.

RELATED COMPANIES Price Int.Val. Rating
AMED Amedisys 119.30 57.53  hold
CIVI Civitas Soluti 16.25 16.70  hold
CHE Chemed 318.20 151.84  sell

COMPANY NEWS

▶ LHC Group (LHCG) Q2 Earnings Beat Estimates   [Aug-02-18 07:30AM  Zacks]
▶ LHC: 2Q Earnings Snapshot   [05:08AM  Associated Press]
▶ LHC Group Announces Second Quarter 2018 Financial Results   [Aug-01-18 05:41PM  Business Wire]
▶ Best NasdaqCM Growth Stocks   [Jun-19-18 12:02PM  Simply Wall St.]
▶ New Strong Buy Stocks for May 30th   [May-30-18 10:23AM  Zacks]
▶ LHC Group to Present at UBS Global Healthcare Conference   [May-17-18 11:31AM  Business Wire]
▶ LHC: 1Q Earnings Snapshot   [May-03-18 05:07AM  Associated Press]
▶ LHC Group Announces First Quarter 2018 Financial Results   [May-02-18 04:30PM  Business Wire]
▶ Signature Healthcare prepping to expand this line of business in 2019   [Apr-12-18 07:03AM  American City Business Journals]
▶ Can The Uptrend Continue for LHC Group (LHCG)?   [Apr-06-18 09:58AM  Zacks]
▶ Almost Family, LHC Group execs on what's next after merger   [07:06AM  American City Business Journals]
▶ Almost Family closes merger to create massive home-health company   [Mar-30-18 10:11AM  American City Business Journals]
▶ LHC Group, Inc. to Host Earnings Call   [Mar-01-18 09:15AM  ACCESSWIRE]
▶ LHC meets 4Q profit forecasts   [Feb-28-18 06:55PM  Associated Press]
▶ Willcare unlikely to be impacted by national healthcare merger   [Feb-01-18 03:10PM  American City Business Journals]
▶ Almost Family merger hits regulatory snag   [Jan-24-18 11:25AM  American City Business Journals]
▶ This global investment firm ups stake in Kindred, Almost Family   [Jan-22-18 12:10PM  American City Business Journals]
▶ ETFs with exposure to LHC Group, Inc. : December 19, 2017   [Dec-19-17 01:31PM  Capital Cube]
▶ One of Louisville's largest public companies is merging, moving HQ   [11:15AM  American City Business Journals]
▶ LHC tops Street 3Q forecasts   [07:35AM  Associated Press]
▶ LHC Group, Inc. to Host Earnings Call   [06:50AM  ACCESSWIRE]
▶ ETFs with exposure to LHC Group, Inc. : August 21, 2017   [Aug-21-17 04:33PM  Capital Cube]
▶ Company Profile for LHC Group   [Aug-11-17 10:40AM  Business Wire]
▶ LHC tops Street 2Q forecasts   [Aug-04-17 12:12AM  Associated Press]
▶ ETFs with exposure to LHC Group, Inc. : July 10, 2017   [Jul-10-17 02:46PM  Capital Cube]
▶ ETFs with exposure to LHC Group, Inc. : June 26, 2017   [Jun-26-17 04:21PM  Capital Cube]
▶ Insiders Roundup: Medley Capital, LHC Group   [Jun-09-17 05:27PM  GuruFocus.com]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.